StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Strongly positive analyst view, but the large implied upside is speculative and not independently corroborated by the provided facts.
What happened, with direct paths to the underlying reporting
Wedbush raised its CLYM price target to $27 from an indicated price of $8.55 and says the stock remains on its Best Ideas List. The target implies substantial upside, though it is an analyst opinion.
Target: $27
Posted price: $8.55
Analyst firm: Wedbush
Analyst: Laura Chico
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.